Clinical Trials In Indianapolis

Discover hundreds of clinical trials in Indianapolis.
Search clinical trials in Indianapolis by condition or phase.

e.g. Respiratory Diseases

Indianapolis•Healthy volunteers: No

Filter results

Results: 901

Structure and Function of Retinal Disease

Recruiting

Sponsor:

Indiana University

Location:

Bloomington

Code:

NCT05643157

Conditions

Retinal Toxicity

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Adaptive Optics - Optical Coherence Tomography (AO-OCT) retinal imaging

A Study to Assess Change in Disease Activity and Adverse Events (AEs) With Cariprazine in the Treatment of Depressive Episodes in Pediatric Participants Participants (10 to 17 Years of Age) With Bipolar I Disorder.

Recruiting

PHASE3

Sponsor:

AbbVie

Location:

Indianapolis, Cincinnati, Chicago, Napervilleshow 42 more

Code:

NCT04777357

Conditions

Depression

Bipolar I Disorder

Eligibility Criteria

Sex: All

Age: 10 - 17

Healthy Volunteers: Not accepted

Interventions

Cariprazine

Placebo

Academic-Community EPINET (AC-EPINET)

Recruiting

Sponsor:

Indiana University

Location:

Indianapolis, Columbus, Ann Arbor, Nashvilleshow 2 more

Code:

NCT04497857

Conditions

Schizophrenia

Schizoaffective Disorder

Schizophreniform Disorders

Major Depression with Psychotic Features

Bipolar Disorder with Psychotic Features

Eligibility Criteria

Sex: All

Age: 16 - 35

Healthy Volunteers: Not accepted

Interventions

Coordinated Specialty Care (CSC)

Avelumab or Hydroxychloroquine With or Without Palbociclib to Eliminate Dormant Breast Cancer

Recruiting

PHASE2

Sponsor:

Abramson Cancer Center at Penn Medicine

Location:

Indianapolis, Chicago, Nashville, Washingtonshow 3 more

Code:

NCT04841148

Conditions

Breast Cancer

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

HCQ

Avelumab

Palbociclib

A Study of Milvexian in Participants After a Recent Acute Coronary Syndrome

Recruiting

PHASE3

Sponsor:

Janssen Research & Development, LLC

Location:

Muncie, Richmond, Kettering, Louisvilleshow 147 more

Code:

NCT05754957

Conditions

Acute Coronary Syndrome

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Milvexian

Placebo

A Study of the Drugs Selumetinib Versus Carboplatin/Vincristine in Patients With Neurofibromatosis and Low-Grade Glioma

Recruiting

PHASE3

Sponsor:

National Cancer Institute (NCI)

Location:

Indianapolis, Cincinnati, Dayton, Louisvilleshow 99 more

Code:

NCT03871257

Conditions

Low Grade Glioma

Neurofibromatosis Type 1

Visual Pathway Glioma

Eligibility Criteria

Sex: All

Age: 2 - 21

Healthy Volunteers: Not accepted

Interventions

Carboplatin

Magnetic Resonance Imaging

Quality-of-Life Assessment

Questionnaire Administration

Selumetinib Sulfate

Registry of Patients With a Diagnosis of Spinal Muscular Atrophy (SMA)

Recruiting

Sponsor:

Novartis Pharmaceuticals

Location:

Indianapolis, Cincinnati, Louisville, Columbusshow 44 more

Code:

NCT04174157

Conditions

Spinal Muscular Atrophy (SMA)

Eligibility Criteria

Sex: All

Age: 0 - 70+

Healthy Volunteers: Not accepted

Interventions

Prospective observational registry

Zolgensma

AGN-193408 SR in the Treatment of Open-angle Glaucoma or Ocular Hypertension

Recruiting

PHASE1

PHASE2

Sponsor:

AbbVie

Location:

Indianapolis, Carmel, Saint Louis, Chesterfieldshow 27 more

Code:

NCT04499248

Conditions

Open-angle Glaucoma

Ocular Hypertension

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

AGN-193408 SR

Lumigan

Sham Administration

Lumigan Vehicle

HF2 Registry - Hemodynamic Frontiers in Heart Failure Registry

Recruiting

Sponsor:

University of Kansas Medical Center

Location:

Bloomington, Kansas City, Columbia, Raleighshow 7 more

Code:

NCT06425848

Conditions

Heart Failure

Eligibility Criteria

Sex: All

Age: 18 - 70+

Healthy Volunteers: Not accepted

Interventions

Observational

Safety and Preliminary Efficacy Trial of BNT142 in Patients With CLDN6-positive Solid Tumors

Recruiting

PHASE1

PHASE2

Sponsor:

BioNTech SE

Location:

Indianapolis, Durham, Fairfax, Baltimoreshow 4 more

Code:

NCT05262530

Conditions

Solid Tumor

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

BNT142